Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · IEX Real-Time Price · USD
29.23
+0.38 (1.32%)
At close: Apr 24, 2024, 4:00 PM
29.35
+0.12 (0.41%)
After-hours: Apr 24, 2024, 6:02 PM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $1.66 billion as of April 24, 2024. Its market cap has decreased by -16.55% in one year.
Market Cap
1.66B
Enterprise Value
1.50B
1-Year Change
-16.55%
Ranking
Category
Stock Price
$29.23
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $1.51B to $1.66B, an increase of 9.78%. That is a compound annual growth rate of 2.57%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 1.64B | -1.70% |
Apr 22, 2024 | 1.67B | -0.17% |
Apr 19, 2024 | 1.67B | 1.27% |
Apr 18, 2024 | 1.65B | -0.55% |
Apr 17, 2024 | 1.66B | -1.98% |
Apr 16, 2024 | 1.69B | 0.88% |
Apr 15, 2024 | 1.68B | 0.07% |
Apr 12, 2024 | 1.67B | -5.63% |
Apr 11, 2024 | 1.77B | 6.44% |
Apr 10, 2024 | 1.67B | -4.83% |
Apr 9, 2024 | 1.75B | 3.42% |
Apr 8, 2024 | 1.69B | -2.64% |
Apr 5, 2024 | 1.74B | -1.86% |
Apr 4, 2024 | 1.77B | -1.48% |
Apr 3, 2024 | 1.80B | -3.05% |
Apr 2, 2024 | 1.86B | -0.94% |
Apr 1, 2024 | 1.87B | -1.70% |
Mar 28, 2024 | 1.91B | 0.18% |
Mar 27, 2024 | 1.90B | 4.69% |
Mar 26, 2024 | 1.82B | -1.78% |
Mar 25, 2024 | 1.85B | -2.13% |
Mar 22, 2024 | 1.89B | -0.71% |
Mar 21, 2024 | 1.90B | -0.28% |
Mar 20, 2024 | 1.91B | 4.07% |
Mar 19, 2024 | 1.84B | 2.34% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Myriad Genetics | 1.67B |
Amneal Pharmaceuticals | 1.67B |
Recursion Pharmaceuticals | 1.66B |
Supernus Pharmaceuticals | 1.64B |
Avadel Pharmaceuticals | 1.64B |
Neumora Therapeutics | 1.64B |
UFP Technologies | 1.63B |
Inhibrx | 1.62B |